; (B) the aggregate dollar amount of all administrative fees that the PBM received with respect to drugs furnished under such plan from drug manufacturers; (C) the aggregate dollar amount of all rebates described in subparagraph (A) that the PBM did not pass through to such sponsor; (D) the percentage of the aggregate dollar amount of all rebates described in subparagraph (A) that the PBM did not pass through to such sponsor; and (E) with respect to all plans described in subsection (a)(1) for which the PBM manages prescription drug coverage, the highest percentage calculated under subparagraph (D) and the lowest such percentage. ; (2) by redesignating subsections (c) and (d) as subsections (d) and (e), respectively; and (3) by inserting after subsection (b), the following new subsection: (c) Publication of part d information The Secretary shall publish, not less frequently than annually, the information reported under subsection (b) by or on behalf of sponsors described in subsection (a)(1) on a publicly available website, provided that such information shall be made available in a form that does not disclose the identity of a specific plan, the prices charged for specific drugs or classes of drugs, or the amount of any rebates provided for specific drugs or classes of drugs. . 5. Effective date The amendments made by this Act shall take effect January 1, 2024. 6. Regulations Notwithstanding any other provision of law, the Secretary shall initially implement the amendments made by this Act through interim final regulations.